Sandrine Valsesia-Wittmann, Beatrice Clemenceau, Anne-Catherine Jallas, Jean-yves Blay, Aurelien Marabelle, et al.. Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells.
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2013, 1 (Suppl 1), pp.P176.
⟨inserm-00881032⟩